Scholarlink

Purpose <p>Rates of surgery remain relevant for localized Crohn’s disease despite the evolution of novel therapies. However, the effect of immunosuppressive medication on the perioperative outcome including the extent of the resection is still inconclusive and needs to be evaluated.</p> Methods <p>In a single-center study, all patients who received ileocolic resection due to localized Crohn’s disease were retrospectively assessed and divided into two groups depending on previous treatment (preoperative medication versus therapy-naïve). Outcome parameters included patient characteristics, surgical and histopathological aspects.</p> Results <p>Two hundred thirty-seven patients were analyzed of whom 192 patients received medical treatment prior to surgery. Preoperative treatment had neither an effect on the length of the resected specimen (29.4&#xa0;cm versus 27.1&#xa0;cm, <i>p</i> = 0.27) nor on the postoperative outcome. Only rates of conversion were significantly increased for therapy-naïve patients compared to patients receiving preoperative treatment (15.6% versus 5.7%, <i>p</i> = 0.025).</p> Conclusion <p>Preoperative medical treatment does not have an effect on the extent of the resected bowel segment in patients suffering from localized Crohn’s disease.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Preoperative immunosuppressive therapy might not affect the length of resected bowel in patients receiving ileocolic resection for Crohn’s disease

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年6月5日

查看全文
  • Matthias Kelm,
  • Michaela Bredl,
  • Anna Widder,
  • Katrin Schoettker,
  • Markus Brand,
  • Alexander Meining,
  • Regina Pistorius,
  • Joachim Reibetanz,
  • Nicolas Schlegel,
  • Christoph-Thomas Germer,
  • Sven Flemming

摘要

Purpose

Rates of surgery remain relevant for localized Crohn’s disease despite the evolution of novel therapies. However, the effect of immunosuppressive medication on the perioperative outcome including the extent of the resection is still inconclusive and needs to be evaluated.

Methods

In a single-center study, all patients who received ileocolic resection due to localized Crohn’s disease were retrospectively assessed and divided into two groups depending on previous treatment (preoperative medication versus therapy-naïve). Outcome parameters included patient characteristics, surgical and histopathological aspects.

Results

Two hundred thirty-seven patients were analyzed of whom 192 patients received medical treatment prior to surgery. Preoperative treatment had neither an effect on the length of the resected specimen (29.4 cm versus 27.1 cm, p = 0.27) nor on the postoperative outcome. Only rates of conversion were significantly increased for therapy-naïve patients compared to patients receiving preoperative treatment (15.6% versus 5.7%, p = 0.025).

Conclusion

Preoperative medical treatment does not have an effect on the extent of the resected bowel segment in patients suffering from localized Crohn’s disease.